Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
CSL Behring
With
ICON Clinical Research
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Definite or probable CIDP according to the European Federation of Neurological Societies/Peripheral Nerve Society (EFNS/PNS) criteria 2010.
An IVIG treatment during the last 8 weeks prior to enrollment.
Age ≥18 years.
Written informed consent for study participation obtained before undergoing any study-specific procedures.
You may not be if
Any polyneuropathy of other causes
Any other disease (mainly neurological or chronic orthopedic) that has caused neurological symptoms or may interfere with treatment or outcome assessments
Severe diseases and conditions that are likely to interfere with evaluation of the study product or satisfactory conduct of the study
History of thrombotic episodes within the 2 years prior to enrolment
Known allergic or other severe reactions to blood products including intolerability to previous IVIG
